Hyperpolarized 13C magnetic resonance metabolic imaging: Application to brain tumors

Neuro-Oncology

Volumn 12, Issue 2, 2010, Pages 133-144

  Park, Ilwoo ^a   Larson, Peder E Z ^a   Zierhut, Matthew L ^a   Hu, Simon ^a   Bok, Robert ^a   Ozawa, Tomoko ^b   Kurhanewicz, John ^a   Vigneron, Daniel B ^a   VandenBerg, Scott R ^b   James, C David ^b   Nelson, Sarah J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Dynamic nuclear polarization (DNP); Human glioblastoma xenograft; Hyperpolarized carbon 13 metabolic imaging

Indexed keywords

CARBON 13; GADOLINIUM PENTETATE; LACTIC ACID; LACTIC ACID C 13; PYRUVIC ACID; PYRUVIC ACID C 13; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; BRAIN TUMOR; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; NONHUMAN; RAT; TUMOR DIAGNOSIS; TUMOR XENOGRAFT; ANIMAL; EXPERIMENTAL NEOPLASM; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE RAT; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASMS, EXPERIMENTAL; RADIOPHARMACEUTICALS; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 75849149496     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nop043     Document Type: Article

References (42)

1. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309-314.
2. Kaibara T, Tyson RL, Sutherland GR. Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem Cell Biol. 1998;76(2-3):477-486.
3. Herholz K, Heindel W, Luyten PR, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol. 1992;31(3):319-327.
4. Terpstra M, Gruetter R, High WB, et al. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res. 1998;58(22):5083-5088.
5. 1H magnetic resonance imaging. Cancer Res. 2001;61(14):5595-5600.
6. He Q, Bhujwalla ZM, Glickson JD. Proton detection of choline and lactate in EMT6 tumors by spin-echo-enhanced selective multiple-quantum-coherence transfer. J Magn Reson B. 1996;112(1):18-25.
7. Star-Lack J, Spielman D, Adalsteinsson E, Kurhanewicz J, Terris DJ, Vigneron DB. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson. 1998;133(2):243-254.
8. Sijens PE, Levendag PC, Vecht CJ, van Dijk P, Oudkerk M. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed. 1996;9(2):65-71.
9. Li X, Vigneron DB, Cha S, et al. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol. 2005;26(4):760-769.
10. Saraswathy S, Crawford FW, Lamborn KR, et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol. 2009;91(1):69-81.
11. Kugel H, Heindel W, Ernestus RI, Bunke J, Dumesnil R, Friedmann G. Human brain-tumors - spectral patterns detected with localized H-1 MR spectroscopy. Radiology. 1992;183(3):701-709.
12. 1H magnetic resonance spectroscopy study. NMR Biomed. 1988;1(1):20-26.
13. Wijnen J, Klomp DW, Idema AJ, Galan BE, Heerschap A. (2008) Lactate production in human brain tumor; detection by 13C MRS at 3 T [abstract]. Proc Intl Soc Mag Reson Med. 2815.
14. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2(9):683-693.
15. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354(5):496-507.
16. Heron DE, Andrade RS, Beriwal S, Smith RP. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response. Am J Clin Oncol. 2008;31(4):352-362.
17. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007;11(44):iii-iv, xi-267.
18. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci USA. 2003;100(18):10158-10163.
19. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA. 2003;100(18):10435-10439.
20. Chen AP, Albers MJ, Cunningham CH, et al. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3 T-initial experience. Magn Reson Med. 2007;58(6):1099-1106.
21. Day SE, Kettunen MI, Gallagher FA, et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med. 2007;13(11):1382-1387.
22. Albers MJ, Bok R, Chen AP, et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008;68(20):8607-8615.
23. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 2002;277(26):23111-23115.
24. 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 2006;66(22):10855-10860.
25. Ozawa T, Wang JL, Hu LJ, Bollen AW, Lamborn KR, Deen DF. Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo. 2002;16(1):55-60.
26. Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF. Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures. Int J Radiat Oncol Biol Phys. 2006;66(1):263-270.
27. 13C-1-pyruvate. Magn Reson Med. 2007;58(1):65-69.
28. Derby K, Tropp J, Hawryszko C. Design and evaluation of a novel dualtuned resonator for spectroscopic imaging. J Magn Reson. 1990;86:645-651.
29. 13C. J Magn Reson. 2007;187(2):357-362.
30. 129Xe MR. J Magn Reson B. 1996;113(2):179-183.
31. Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med. 2001;46(2):228-239.
32. Vigneron DB, Nelson SJ, Murphy-Boesch J, et al. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images. Radiology. 1990;177(3):643-649.
33. Bracewell RN. The Fourier Transform and Its Applications. New York: McGraw-Hill; 1978.
34. Yoo H, Baia GS, Smith JS, et al. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res. 2007;13(1):68-75.
35. Subhash MN, Rao BS, Shankar SK. Changes in lactate dehydrogenase isoenzyme pattern in patients with tumors of the central nervous system. Neurochem Int. 1993;22(2):121-124.
36. 13C-pyruvatem [abstract]. Proc Intl Soc Mag Reson Med. 251.
37. Wang J, Klem J, Wyrick JB, et al. Detection of hypoxia in human brain tumor xenografts using a modified comet assay. Neoplasia. 2003;5(4):288-296.
38. Lin RY, Vera JC, Chaganti RS, Golde DW. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998;273(44):28959-28965.
39. Grzybicki DM, Moore SA. Implications of prognostic markers in brain tumors. Clin Lab Med. 1999;19(4):833-847.
40. Reavey-Cantwell JF, Haroun RI, Zahurak M, et al. The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. J Neurooncol. 2001;55(3):195-204.
41. Larson PE, Kerr AB, Chen AP, et al. Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson. 2008;194(1):121-127.
42. Davson H, Zlokovic B, Rakic L, Sega MB. An Introduction to the Blood-Brain Barrier. Boca Raton: CRC Press; 1993.